Ding Wang

1.9k total citations
59 papers, 1.4k citations indexed

About

Ding Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ding Wang has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Ding Wang's work include Mesenchymal stem cell research (6 papers), CRISPR and Genetic Engineering (5 papers) and Neonatal Respiratory Health Research (5 papers). Ding Wang is often cited by papers focused on Mesenchymal stem cell research (6 papers), CRISPR and Genetic Engineering (5 papers) and Neonatal Respiratory Health Research (5 papers). Ding Wang collaborates with scholars based in China, United States and United Kingdom. Ding Wang's co-authors include Lawrence B. Gardner, Scott A. Boerner, Patricia LoRusso, James D. Winkler, Leenus Martin, Xiaofang Sun, Daolin Tang, Rui Kang, Bing Song and Yong Fan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ding Wang

56 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ding Wang China 18 959 302 287 252 138 59 1.4k
Kevin McDonnell United States 16 961 1.0× 499 1.7× 220 0.8× 497 2.0× 117 0.8× 39 1.5k
Sarah Attwell United States 11 1.2k 1.3× 248 0.8× 147 0.5× 251 1.0× 178 1.3× 24 1.7k
Michele Menicagli Italy 19 543 0.6× 245 0.8× 140 0.5× 366 1.5× 246 1.8× 50 1.2k
Michela Pasello Italy 24 869 0.9× 344 1.1× 435 1.5× 475 1.9× 145 1.1× 45 1.8k
Nathan V. Lee United States 14 673 0.7× 312 1.0× 326 1.1× 459 1.8× 58 0.4× 23 1.2k
Cristian Scatena Italy 22 526 0.5× 435 1.4× 220 0.8× 507 2.0× 170 1.2× 67 1.3k
Jin Sung Jang United States 24 1.0k 1.1× 420 1.4× 324 1.1× 516 2.0× 153 1.1× 49 1.7k
Ian A.J. Lorimer Canada 21 710 0.7× 399 1.3× 308 1.1× 518 2.1× 106 0.8× 41 1.3k
Patricia Fergelot France 23 666 0.7× 320 1.1× 579 2.0× 249 1.0× 94 0.7× 70 1.6k
Quteba Ebrahem United States 18 808 0.8× 408 1.4× 107 0.4× 222 0.9× 123 0.9× 31 1.5k

Countries citing papers authored by Ding Wang

Since Specialization
Citations

This map shows the geographic impact of Ding Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Wang more than expected).

Fields of papers citing papers by Ding Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ding Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Wang. The network helps show where Ding Wang may publish in the future.

Co-authorship network of co-authors of Ding Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ding Wang. A scholar is included among the top collaborators of Ding Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ding Wang. Ding Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yongtao, Zhicheng Zhou, Deyong Jia, et al.. (2025). Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer. Oncogene. 44(50). 4868–4877.
2.
3.
Liu, Wenye, et al.. (2024). BF170 hydrochloride enhances the emergence of hematopoietic stem and progenitor cells. Development. 151(13). 3 indexed citations
4.
Mirza, Bilal, Dominic C. M. Ng, Wei Wang, et al.. (2024). Missing Values in Longitudinal Proteome Dynamics Studies: Making a Case for Data Multiple Imputation. Journal of Proteome Research. 23(9). 4151–4162. 2 indexed citations
5.
Zhong, Xinqi, Ding Wang, Shuang Chen, et al.. (2023). Umbilical cord blood–derived exosomes from healthy term pregnancies protect against hyperoxia‐induced lung injury in mice. Clinical and Translational Science. 16(6). 966–977. 11 indexed citations
6.
He, Qiuju, Wen Qi, Zhifa Li, et al.. (2022). Epilepsy Combined With Multiple Gene Heterozygous Mutation. Frontiers in Pediatrics. 10. 763642–763642.
7.
Wang, Ding & Yawei Liu. (2021). Celastrol Inhibits Proliferation and Migration, and Promotes Apoptosis of Colon Cancer Cell HT29. Current Topics in Nutraceutical Research. 20(2). 381–385. 1 indexed citations
8.
Chen, Rui, Yingjun Xie, Xuan Zhong, et al.. (2021). MSCs derived from amniotic fluid and umbilical cord require different administration schemes and exert different curative effects on different tissues in rats with CLP-induced sepsis. Stem Cell Research & Therapy. 12(1). 164–164. 12 indexed citations
9.
Krige, David, Marwan Fakih, Lee S. Rosen, et al.. (2021). 342 Combining enadenotucirev and nivolumab increased tumour immune cell infiltration/activation in patients with microsatellite-stable/instability-low metastatic colorectal cancer in a phase 1 study. Regular and Young Investigator Award Abstracts. A368–A369. 2 indexed citations
10.
Wang, Ding, et al.. (2020). Different culture method changing CD105 expression in amniotic fluid MSCs without affecting differentiation ability or immune function. Journal of Cellular and Molecular Medicine. 24(7). 4212–4222. 15 indexed citations
11.
Xie, Yingjun, Yuhuan Xie, Ding Wang, et al.. (2019). CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells. Annals of Hematology. 98(12). 2661–2671. 8 indexed citations
12.
Lau, Edward, Quan Cao, Maggie P. Y. Lam, et al.. (2018). Integrated omics dissection of proteome dynamics during cardiac remodeling. Nature Communications. 9(1). 120–120. 62 indexed citations
13.
Wang, Ding, et al.. (2017). Cytogenic and molecular studies of male infertility in cases of Y chromosome balanced reciprocal translocation. Molecular Medicine Reports. 16(2). 2051–2054. 7 indexed citations
14.
He, Jialing, Yingjun Xie, Xiaoman Wang, et al.. (2017). Psychomotor retardation with a 1q42.11–q42.12 deletion. Hereditas. 154(1). 6–6. 4 indexed citations
15.
Jacobs, Samuel A., James J. Lee, Thomas J. George, et al.. (2015). Abstract C46: NSABP FC-7: A phase Ib study evaluating neratinib (N) and cetuximab (Cmab) in patients (pts) with quadruple wild-type (quad wt) (KRAS/NRAS/BRAF/PI3KCA wt) metastatic colorectal cancer (mCRC) resistant to Cmab. Molecular Cancer Therapeutics. 14(12_Supplement_2). C46–C46. 1 indexed citations
16.
Song, Bing, Yong Fan, Wenyin He, et al.. (2014). Improved Hematopoietic Differentiation Efficiency of Gene-Corrected Beta-Thalassemia Induced Pluripotent Stem Cells by CRISPR/Cas9 System. Stem Cells and Development. 24(9). 1053–1065. 118 indexed citations
17.
Martin, Leenus, Ding Wang, Jinhua Wang, et al.. (2014). Identification and Characterization of Small Molecules That Inhibit Nonsense-Mediated RNA Decay and Suppress Nonsense p53 Mutations. Cancer Research. 74(11). 3104–3113. 106 indexed citations
18.
Liu, Yi, Ding Wang, Jianwei Zhu, et al.. (2014). NEDD9 overexpression correlates with poor prognosis in gastric cancer. Tumor Biology. 35(7). 6351–6356. 16 indexed citations
19.
Wang, Ding, Ke Chen, Wei Du, et al.. (2010). CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells. Experimental Cell Research. 316(15). 2414–2423. 43 indexed citations
20.
Wang, Ding, Scott A. Boerner, James D. Winkler, & Patricia LoRusso. (2006). Clinical experience of MEK inhibitors in cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773(8). 1248–1255. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin McDonnell Breakdown of academic impact, for papers by Sarah Attwell Breakdown of academic impact, for papers by Michele Menicagli Breakdown of academic impact, for papers by Michela Pasello Breakdown of academic impact, for papers by Nathan V. Lee Breakdown of academic impact, for papers by Cristian Scatena Breakdown of academic impact, for papers by Jin Sung Jang Breakdown of academic impact, for papers by Ian A.J. Lorimer Breakdown of academic impact, for papers by Patricia Fergelot Breakdown of academic impact, for papers by Quteba Ebrahem
Rankless by CCL
2026